Monday, December 29, 2014

Denver Health's new NHBS website

Visit the new site

The National HIV Behavioral Surveillance (NHBS) system is funded by the Centers for Disease Control and Prevention (CDC) to monitor risk behaviors and access to HIV prevention services among three populations at risk for HIV:
  • Men who have sex with men (MSM)
  • Injection drug users (IDU)
  • Heterosexuals at increased risk for HIV (HET)
Denver is one of 20 sites across the United States collecting NHBS data. Locally, NHBS is known as REACH (Risk Education Aimed at Community Health). REACH data is used to guide prevention, and HIV counseling and testing services in the Denver Metro area. NHBS data also provides a behavioral context for trends seen in HIV surveillance throughout the United States.

Friday, December 19, 2014

New Collaborative Guidelines for HIV Prevention with Persons with HIV

Dear Ryan White HIV/AIDS Program Colleagues:

On December 11, 2014, CDC, HRSA, NIH, the American Academy of HIV Medicine, the Association of Nurses in AIDS Care, the International Association of Providers of AIDS Care, the National Minority AIDS Council, and the Urban Coalition for HIV/AIDS Prevention Services (UCHAPS) issued Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014. This guideline updates the 2003 guideline,Incorporating HIV Prevention into the Medical Care of Persons Living with HIV: Recommendations of CDC, HRSA, NIH, and the HIV Medicine Association of the Infectious Diseases Society of America. The new guideline compiles new and longstanding federal recommendations about biomedical, behavioral, and structural interventions to reduce HIV transmission from persons with HIV. Three Summaries list the subset of recommendations for each of the guideline’s audiences: clinical providers, nonclinical providers, and health department staff. An online resource library includes links to practical implementation resources, such as decision-support tools, fact sheets for providers and persons with HIV, and training materials: .


Division of State HIV/AIDS Programs (DSHAP)
Health Resources and Services Administration (HRSA)

Wednesday, December 17, 2014

CDC's Recommendations for HIV Prevention with Adults and Adolescents with HIV in the US, 2014

Dear Colleague,

This week, the Centers for Disease Control and Prevention (CDC), in collaboration with the HIV/AIDS Bureau at the Health Resources and Services Administration (HRSA), the National Institutes of Health (NIH), and five participating CDC partner organizations, published a new evidence-based guideline, Recommendations for HIV Prevention with Adults and Adolescents with HIV in the United States, 2014 updating and expanding the 2003 recommendations. The recommendations comprise an all-in-one set of comprehensive interventions for clinical providers, nonclinical providers, as well as staff of health departments and HIV planning groups focused on optimizing health outcomes for people with HIV and reducing their risk of exposing others to HIV.

Monday, December 15, 2014

NIH's AIDSinfo Mobile Apps

AIDSinfo creates mobile applications for popular AIDSinfo features. These apps allow access to federally approved HIV/AIDS treatment and research information optimized for mobile devices and are offered free of charge.

Drug Database

This app provides access to the same drug information provided by theAIDSinfo Drug Database. The app includes two versions of each drug summary—one for consumers (English and Spanish) and one for health care professionals. The app automatically refreshes content, so the information is always up to date.

Available for:

iPhone, iPad, and iPod Touch

Android device


The AIDSinfo HIV/AIDS Glossary app provides access to the same terms found in the AIDSinfo Glossary of HIV/AIDS-Related Terms. The app includes English and Spanish definitions of more than 700 HIV/AIDS-related terms.

Available for:

iPhone, iPad, and iPod Touch

Download the Glossary App for your Android device

Wednesday, December 3, 2014

Funding Opportunity: People Who Inject Drugs Living with HIV/Hep C RFA

Janssen Therapeutics Request for Applications (RFA):

"Improving Care and Treatment for People Who Inject Drugs (PWID) Living with HIV and/or Hepatitis C"

Area of Interest

Comprehensive community-based models that enhance the ability of PWID living with HIV and/or HCV to access care and treatment

Eligible Applicants

501(c)(3) tax-exempt, community-based organizations in the US that work with PWID living with HIV and/or HCV

One year charitable contribution of up to $40,000


November 25, 2014 - January 31, 2015 (Applications will be reviewed and funded on a rolling basis through early 2015)


Applications must be submitted online through Janssen’s charitable contribution application system

Application Process

Please note: Applications will only be accepted via the Charitable Contributions portal. Educational grants will not be considered.

Visit for more information or email questions to .